Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
(NQ:
)
N/A
UNCHANGED
Last Price
/ Updated:
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
-
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Top News
More News
Pharmacyclics, Inc. Announces Board and Management Transitions
September 11, 2008
from
PR Newswire
Cell Therapeutics (CTIC) Announces 1-for-10 Reverse Stock Split
August 25, 2008
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=3937620 for the full story.
Read More
from
StreetInsider.com News Articles
More News
Read More
BellwetherReport.com Analyst Report on TTWO, DYAX, FMCN and CTIC
August 18, 2008
from
Marketwired News Releases
Cell Therapeutics, Inc. (CTI) to Report 2008 Second Quarter Financial Results on August 18
August 14, 2008
from
PR Newswire
Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Me
August 12, 2008
from
PR Newswire
Craig W. Philips Takes Helm at CTI
August 05, 2008
from
PR Newswire
Cell Therapeutics, Inc. Announces $12 Million Equity Line of Credit
July 29, 2008
from
PR Newswire
Cell Therapeutics, Inc. Announces $12 Million Equity Line of Credit
July 29, 2008
category
Health Care
from
FOXBusiness.com
Congress Extends 2007 Reimbursement Rates for Radioimmunotherapies for 18 Months
July 09, 2008
from
PR Newswire
Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology
July 07, 2008
from
PR Newswire
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here